Размер шрифта
Цветовая схема
Изображения
Форма
Межсимвольный интервал
Межстрочный интервал
стандартные настройки
обычная версия сайта
закрыть
  • Вход
  • Регистрация
  • Помощь
Выбрать БД
Простой поискРасширенный поискИстория поисков
Главная / Результаты поиска

Dynamics of polymetabolic disorders and mitochondrial dysfunction in women after hysterectomy

Подзолкова Н. М., Подзолков В. И., Брагина А. Е., Никитина Т. И.
Вопросы гинекологии, акушерства и перинатологии
Т. 18, Вып. 3, С. 5-14
Опубликовано: 2019
Тип ресурса: Статья

DOI:10.20953/1726-1678-2019-3-5-14

Аннотация:
The objective. Assessment of the development and progression of metabolic abnormalities in women after hysterectomy (HE) with removal/conservation of the ovaries, and the potential of drug therapy for their management. Patients and methods. We examined 138 women of late reproductive age and early menopausal transition after HE with both ovaries removed and 130 women after HE with unilateral adnexectomy. The control group comprised 40 women of similar age. We assessed the blood pressure level (BP), body mass index (BMI), parameters of lipid and carbohydrate metabolism, activity of mitochondrial enzymes in peripheral blood lymphocytes. Therapy was administered in 93 patients, including tibolone 2.5 mg (orally), or 17β-estradiol 1.5 mg (transdermally), or nonhormonal medications (antioxidants, vitamin-mineral complex). Results. During the first 9–12 months after surgery, characteristic complaints appeared in 10.7[%] of the examined women after HE with adnexal conservation (group 1) and in 2
Ключевые слова:
Menopausal replacement therapy; Metabolic disorders; Mitochondrial dysfunction; Post-hysterectomy syndrome
estradiol; mitochondrial enzyme; tibolone; Article; blood pressure; body mass; carbohydrate metabolism; climacterium; controlled study; disorders of mitochondrial functions; female; human; hysterectomy; lipid metabolism; lymphocyte; major clinical study; metabolic disorder; peripheral lymphocyte
Язык текста: Русский
ISSN: 2414-9152
Подзолкова Н. М.
Подзолков В. И. Валерий Иванович 1948-
Брагина А. Е. Анна Евгеньевна 1973-
Никитина Т. И.
Podzolkova N. M.
Podzolkov V. I. Valerij Ivanovich 1948-
Bragina A. E. Anna Evgenyevna 1973-
Nikitina T. I.
Dynamics of polymetabolic disorders and mitochondrial dysfunction in women after hysterectomy
Текст визуальный непосредственный
Вопросы гинекологии, акушерства и перинатологии
ООО "Издательство "Династия"
Т. 18, Вып. 3 С. 5-14
2019
Статья
Menopausal replacement therapy Metabolic disorders Mitochondrial dysfunction Post-hysterectomy syndrome
estradiol mitochondrial enzyme tibolone Article blood pressure body mass carbohydrate metabolism climacterium controlled study disorders of mitochondrial functions female human hysterectomy lipid metabolism lymphocyte major clinical study metabolic disorder peripheral lymphocyte
The objective. Assessment of the development and progression of metabolic abnormalities in women after hysterectomy (HE) with removal/conservation of the ovaries, and the potential of drug therapy for their management. Patients and methods. We examined 138 women of late reproductive age and early menopausal transition after HE with both ovaries removed and 130 women after HE with unilateral adnexectomy. The control group comprised 40 women of similar age. We assessed the blood pressure level (BP), body mass index (BMI), parameters of lipid and carbohydrate metabolism, activity of mitochondrial enzymes in peripheral blood lymphocytes. Therapy was administered in 93 patients, including tibolone 2.5 mg (orally), or 17β-estradiol 1.5 mg (transdermally), or nonhormonal medications (antioxidants, vitamin-mineral complex). Results. During the first 9–12 months after surgery, characteristic complaints appeared in 10.7[%] of the examined women after HE with adnexal conservation (group 1) and in 2